Ebola | ||||||
NEWS | ||||||
Stock Rating Runner: Arbutus Biopharma (NASDAQ:ABUS) Gains a Vote of Confidence From ... ... GI-NET and ACC, HCC, TKM-Ebola, TKM-Ebola-Guinea, TKM-Marburg, TKM-HTG and TKM-ALDH which are in different clinical trial stage. Arbutus ...
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar